Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

1794P - Rapid diagnosis of liquid biopsy in non-small cell lung cancer by the EGFR-LAMP assay

Date

16 Sep 2021

Session

ePoster Display

Presenters

Yuichi Saito

Citation

Annals of Oncology (2021) 32 (suppl_5): S1211-S1226. 10.1016/annonc/annonc716

Authors

Y. Saito1, A. MATSUI2, S. MICHIYUKI2, H. MOROOKA3, T. IBI3, Y. YAMAUCHI1, N. TAKAHASHI3, Y. SHIMIZU4, T. IKEYA3, E. HOSHI3, Y. SAKAO1, M. KAWAMURA1

Author affiliations

  • 1 Department Of Surgery, Teikyo University School of Medicine, 1738605 - Tokyo/JP
  • 2 Fundamental Technology Research Department, Eiken Chemical Co., Ltd., 3240036 - Tochigi/JP
  • 3 Department Of Thoracic Surgery, Saitama Cardiovascular and Respiratory Center, 3600197 - Saitama/JP
  • 4 Department Of Pathology, Saitama Cardiovascular and Respiratory Center, 3600197 - Saitama/JP
More

Abstract 1794P

Background

Liquid biopsy has been adopted into one of diagnostic tests of EGFR mutation for patients with advanced or metastatic non-small cell lung cancer (NSCLC). Loop-mediated isothermal amplification (LAMP) has been widely used for the rapid detection in virology or bacteriology, which allows quick amplification of DNA (60 min) with certain cost-effectiveness (WHO recommendations on the use of TB-LAMP presents the price per test is 7 euros). Theoretically, LAMP could enable us to make a quick diagnosis of oncogene as well. Here we developed a set of unique primers for detecting EGFR mutations, and investigated the efficacy of EGFR-LAMP assay using plasma samples of patients with resected NSCLC tumor.

Methods

All samples were collected from patients with suspected primary lung cancer at Saitama Cardiovascular and Respiratory Center between January 2019 and September 2020. All tumor tissues were taken by surgery or surgical biopsy, and the EGFR status of them were investigated by the Therascreen EGFR PCR Kit. Among them, only cases with EGFR mutated tumors were selected for further investigation. The LAMP and NGS assays were conducted for DNA products extracted from preoperative plasma samples. The detection rates of both assays were calculated and compared each other.

Results

Among 57 EGFR mutated tumors or metastatic lymph nodes, 51 preoperative plasma specimens were available for investigation of EGFR status by the NGS and the LAMP assays. The NGS assay detected only 2 EGFR-mutated samples (2/51), one of which showed EGFR mutation by the LAMP assay (1/51). The detection rates of EGFR mutation were extremely low in both assays (1.9% in the LAMP assay, and 3.9% in the NGS assay, respectively). The two cases were advanced papillary adenocarcinoma showing IIIA and IVA in pathological stage, while most of remaining cases consisted of stage I-II lung cancer (44/49).

Conclusions

This is the first report of LAMP liquid biopsy detecting oncogene in a plasma sample. The EGFR-LAMP assay similar performance to the NGS assay in terms of detecting EGFR mutation in NSCLC tumors. The LAMP assay has advantage of time-saving, cost-effective, and simple test compared to the NGS assay. However, further investigation is required for development of more sensitive assay.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Eiken Chemical Co., Ltd.

Disclosure

A. Matsui, S. Michiyuki: Financial Interests, Personal and Institutional, Full or part-time Employment: Eiken Chemical Co., Ltd. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.